Wen Qing Liang
Directeur Général chez CF PharmTech, Inc
Profil
Wen Qing Liang is currently the Chairman & General Manager at CF PharmTech, Inc since 2020.
Prior to this, he had worked at CF PharmTech, Inc since 2013.
Dr. Liang holds a doctorate degree from the University of Massachusetts, which he received in 1996.
Postes actifs de Wen Qing Liang
| Sociétés | Poste | Début |
|---|---|---|
CF PharmTech, Inc
 CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Directeur Général | 17/09/2020 |
Formation de Wen Qing Liang
| University of Massachusetts | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CF PharmTech, Inc
CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Health Technology |
